Issue 1/2023
Content (24 Articles)
Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry
Dapeng Sun, Raynald -, Xiaochuan Huo, Baixue Jia, Xu Tong, Gaoting Ma, Anxin Wang, Ning Ma, Feng Gao, Dapeng Mo, Zhongrong Miao
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
Xiaojie Zheng, Fangbo Gao, Le Wang, Yao Meng, Walter Ageno, Xingshun Qi
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
Julie Wang, Hui Yin Lim, Rowena Brook, Jeffrey Lai, Harshal Nandurkar, Prahlad Ho
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
Ioannis Lianos, Charalampos Varlamos, Despoina-Rafailia Benetou, Christos Mantis, Konstantinos Kintis, Vassiliki-Maria Dragona, Ioannis Kanakakis, Dimitrios Sionis, Sotirios Patsilinakos, Dimitrios Alexopoulos
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism
Giuseppe Fiorentino, Giuditta Benincasa, Antonietta Coppola, Monica Franzese, Anna Annunziata, Ornella Affinito, Mario Viglietti, Claudio Napoli
l-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates
Saeede Bagheri, Shahram Samiee, Mahin Nikougoftar Zarif, Mohammad Reza Deyhim
Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest
XinLiang Guan, Lei Li, XuRan Lu, Ming Gong, HaiYang Li, YuYong Liu, WenJian Jiang, Feng Lan, XiaoLong Wang, HongJia Zhang
Four-factor prothrombin complex concentrate use for on-label versus off-label indications: a retrospective cohort study
Brian D. Adkins, Hila Shaim, Abdul Abid, Adam Gonzalez, Abe DeAnda Jr., Sean G. Yates
Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis
Tiffany T. S. Ye, Qi Zhuang Siah, Benjamin Y. Q. Tan, Jamie S. Y. Ho, Nicholas L. X. Syn, Yao Hao Teo, Yao Neng Teo, James W. Yip, Tiong-Cheng Yeo, Weiqin Lin, Raymond C. C. Wong, Ping Chai, Bernard Chan, Vijay Kumar Sharma, Leonard L. L. Yeo, Ching-Hui Sia
Net clinical benefit of DOACs vs. usual anticoagulation treatment in venous thromboembolism and active cancer: systematic review and meta-analysis
Helena Michalopoulou, Dimitris Polyzos, Costas Thomopoulos, George Makavos, George-Aggelos Papamikroulis, Alexandrina Nikova, George Ε. Zakynthinos, Michail Vavouranakis, Gerasimos Siasos, Emmanouil Vavouranakis
Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosis
Javad Ahmadi, Ehteramolsadat Hosseini, Faranak Kargar, Mehran Ghasemzadeh
Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions
Fan Zhang, Xudong Cao, Chunhui Zhao, Li Chen, Xiaolin Chen
A multicentre observational study of the prevalence, management, and outcomes of subsegmental pulmonary embolism
Michael N Armitage, Aishah Z Mughal, Christopher C Huntley, Daniel Lasserson, Michael Newnham
Time from blood draw to multiple electrode aggregometry and association with platelet reactivity
David Hesselbarth, Diona Gjermeni, Sofia Szabo, Patrick M. Siegel, Philipp Diehl, Martin Moser, Christoph Bode, Christoph B. Olivier
Higher OAK (Oral Anticoagulation Knowledge) score at baseline associated with better TTR (Time in Therapeutic Range) in patients taking warfarin
Delaney Feldeisen, Constantina Alexandris-Souphis, Brian Haymart, Xiaokui Gu, Linda Perry, Stephanie Watts, Renee Kozlowski, Jay Kozlowski, James B. Froehlich, Geoffrey D. Barnes, Eva Kline-Rogers
Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
Camille Troyer, Wesley Nguyen, Annie Xie, Dexter Wimer
Temporal trend in venous thromboembolism hospitalization rates in Brazilian older adults, 2010–2020
Milara Barp, Viviane Santos Mendes Carneiro, Suelen Gomes Malaquias, Valéria Pagotto
Impact of clinical profile at admission on the outcomes in patients hospitalized for acute pulmonary embolism: data from the IPER Registry
Marco Zuin, Claudio Bilato, Amedeo Bongarzoni, Pietro Zonzin, Franco Casazza, Gianluca Rigatelli, Loris Roncon
Use of SAMe-TT2R2 in a racially diverse anticoagulation clinic: prediction of optimal anticoagulation
Kunkun Wang, Yun Lu, Mengistu A Simegn, Haoran Xue, Richard W Asinger
TAVR: nemesis of NOACs?
Amin Polzin, Carolin Helten, Daniel Metzen, Saif Zako, Verena Veulemans, Malte Kelm, Tobias Zeus
Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants
Anisa Amirtabar, Sara R. Vazquez, John Saunders, Daniel M. Witt
Association between thromboembolic events and COVID-19 infection within 30 days: a case–control study among a large sample of adult hospitalized patients in the United States, March 2020–June 2021
Ya-Lin A. Huang, Hussain Yusuf, Alys Adamski, Joy Hsu, James Baggs, Rehab Auf, Stacey Adjei, Rhett Stoney, W. Craig Hooper, Eloisa Llata, Emilia H. Koumans, Jean Y. Ko, Sebastian Romano, Tegan K. Boehmer, Aaron M. Harris
Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison
Samantha Pasca, PierGiorgio Cojutti, Federico Pea, Ezio Zanon